1. Chilton, Ilana, Okur, Volkan, Vitiello, Giuseppina, Gripp, Karen W, Chung, Wendy K. 2020. De novo heterozygous missense and loss-of-function variants in CDC42BPB are associated with a neurodevelopmental phenotype. In American journal of medical genetics. Part A, 182, 962-973. doi:10.1002/ajmg.a.61505. https://pubmed.ncbi.nlm.nih.gov/32031333/
2. Deshpande, Ravindra Pramod, Wu, Kerui, Wu, Shih-Ying, Li, Wencheng, Watabe, Kounosuke. 2024. Tumor-intrinsic CDC42BPB confers resistance to anti-PD-1 immune checkpoint blockade in breast cancer. In Molecular therapy : the journal of the American Society of Gene Therapy, 32, 3669-3682. doi:10.1016/j.ymthe.2024.07.021. https://pubmed.ncbi.nlm.nih.gov/39086134/
3. Huang, Wen, Yuan, Wei, Ren, Lei, Xu, Mian, Hou, Yingyong. 2022. A novel fusion between CDC42BPB and ALK in a patient with quadruple wild-type gastrointestinal stromal tumor. In Molecular genetics & genomic medicine, 10, e1881. doi:10.1002/mgg3.1881. https://pubmed.ncbi.nlm.nih.gov/35319816/
4. Li, Jiao, Wang, Fei, Li, Zhen, Chai, Guoliang, Hao, Junwei. 2024. Integrative multi-omics analysis identifies genetically supported druggable targets and immune cell specificity for myasthenia gravis. In Journal of translational medicine, 22, 302. doi:10.1186/s12967-024-04994-2. https://pubmed.ncbi.nlm.nih.gov/38521921/
5. Luo, Li-Jing, Feng, Fan, Li, Sheng-Hui, Li, Lin, Zhou, Qi. 2020. Sequence variant in the CDC42BPB gene is potentially associated with Mullerian duct anomalies. In The journal of obstetrics and gynaecology research, 46, 684-693. doi:10.1111/jog.14211. https://pubmed.ncbi.nlm.nih.gov/32043305/
智鼠故事 
